Skip to main content
Fig. 1 | Journal for ImmunoTherapy of Cancer

Fig. 1

From: Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results

Fig. 1

Disease-free survival and overall survival in treated patients. Disease-free survival according to stage of the disease in melanoma patients treated with AGI-101H in Trial 3 (a) and Trial 5 (b). Overall survival according to stage of the disease in melanoma patients treated with AGI-101H in Trial 3 (a) and Trial 5 (b)

Back to article page